title: Alemtuzumab for refractory celiac disease.
authors.forename: Wieke H M
authors.initials: WH
authors.lastname: Verbeek
authors.forename: Chris J J
authors.initials: CJ
authors.lastname: Mulder
authors.forename: Sonja
authors.initials: S
authors.lastname: Zweegman
mesh_terms: D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002446:Celiac Disease / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab